18 February 2026

Eden Research plc

("Eden Research" or the "Company")

Result of General Meeting, Director Shareholdings and Total Voting Rights

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, announces that all resolutions put to Shareholders at the General Meeting held earlier today in connection with the Placing, Subscription and Retail Offer, as announced by the Company on 2 February 2026, were duly passed.

The total number of votes received by proxy on each resolution, as more fully disclosed in the Notice of General Meeting available on the Company's website, was as follows:

·      A vote Withheld is not a vote in law and is not counted in the calculation of the votes cast For or Against the resolution, nor in the calculation of the percentage of issued share capital voted for any resolution.

·      Votes For and Against are expressed as a percentage of votes validly cast for that resolution by proxy, excluding any Withheld votes.

 Director Shareholdings

The following Directors subscribed for New Ordinary Shares pursuant to the Fundraising. The number of new Ordinary Shares subscribed for by each Director and their resulting shareholdings upon Admission are set out below:

(1)  The number of Ordinary Shares presented in this table as being held or subscribed for by Directors refers to the number of Ordinary Shares held or subscribed for by them either personally or through a nominee.

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further details.

Admission and Total Voting Rights

Following shareholder approval at the general meeting and conditional on First Admission, a total of 80,010,471 New Ordinary Shares (comprising 74,875,000 Firm Placing Shares, 1,375,000 Firm Subscription Shares and 3,760,471 Retail Offer Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 19 February 2026.

Following First Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 613,362,994 with each Ordinary Share carrying the right to one vote. There are no shares held in treasury and therefore, following Admission, the total number of voting rights in the Company will be 613,362,994.

The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

Capitalised terms used in this announcement have the meaning given to them in the announcement dated 2 February 2026 and 6 February 2026, unless otherwise defined in this announcement.

Enquiries:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.